Skip to content
Peptigraph home

Tirzepatide for Sleep Apnea: What the Evidence Shows

What human and animal studies show about Tirzepatide for sleep apnea, how strong that evidence is, and what is still unproven.

Medically reviewed by Juan Pablo Frías, MD · · DisclosureGLP-1 / GIP dual agonistUpdated
Strongest evidence
Human RCT
Human studies
1
with an outcome for sleep apnea, in our evidence file (PubMed search, 2 Oct 2026)
Animal studies
None found
with an outcome for sleep apnea, in our evidence file (PubMed search, 2 Oct 2026)
Studies we summarised
1
with an outcome for sleep apnea

Evidence for sleep apnea

Each row is an outcome related to sleep apnea from a published study, strongest design first. Animal and cell results are labelled and are not human results. User reports are not counted as evidence here.

Tirzepatide for sleep apnea: outcomes in published studies
OutcomeResultStudy typeSource
Apnea-hypopnea index, trial 1 (no PAP)Trial 1: AHI fell by 25.3 events per hour with tirzepatide versus 5.3 with placebo at week 52.Human RCTThe New England journal of medicine 2024, PMID 38912654
Apnea-hypopnea index, trial 2 (on PAP)Trial 2: AHI fell by 29.3 events per hour with tirzepatide versus 5.5 with placebo at week 52.Human RCTThe New England journal of medicine 2024, PMID 38912654

Tirzepatide and sleep apnea are not in our PubMed count ledger yet; the rows above come from our evidence file (PubMed search, 2 Oct 2026). Grades follow our evidence scale.

How strong is it?

Strongest evidence:Human RCT evidence, 4 of 4The New England journal of medicine 2024, PMID 38912654

A human randomized trial outweighs any number of animal studies. Animal and cell results show a mechanism worth testing, not that it works in people.

Other peptides people research for sleep apnea

No other peptide in our index has a sleep apnea page yet.

Common questions

Does Tirzepatide help with sleep apnea?

The strongest study we summarise for sleep apnea is human rct evidence, across 1 study with an outcome for sleep apnea. A trial result is not an approval; see the legal status.

Is Tirzepatide approved for sleep apnea?

Tirzepatide is FDA approved (Mounjaro, Zepbound). Which conditions that approval covers is set by the label; use for anything else is off-label.

More on Tirzepatide

DosageDoses used in published studies, with the source for each.CalculatorVial, water and dose to syringe units.Side effectsWhat labels and studies report, and what is unknown.ResultsStudy outcomes and when they were measured.PricePrice per mg and per week from dated listings. No vendor links.Legal statusFDA, compounding and WADA status with dates.

Sources

  1. 1Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity.The New England journal of medicine · 2024PMID 38912654Accessed 2 Oct 2026

Found an error? Report a correction.